Related Experiment Video
Updated: Jun 17, 2026
Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's
Kanae Iijima-Ando1, Stephen A Hearn, Christopher Shenton
1Laboratory of Neurogenetics and Pathobiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Kanae.Iijima-Ando@jefferson.edu
Abstract:
The amyloid-beta 42 (Abeta42) is thought to play a central role in the pathogenesis of Alzheimer's disease (AD). However, the molecular mechanisms by which Abeta42 induces neuronal dysfunction and degeneration remain elusive. Mitochondrial dysfunctions are implicated in AD brains. Whether mitochondrial dysfunctions are merely a consequence of AD pathology, or are early seminal events in AD pathogenesis remains to be determined. Here, we show that Abeta42 induces mitochondrial mislocalization, which contributes to Abeta42-induced neuronal dysfunction in a transgenic Drosophila model. In the Abeta42 fly brain, mitochondria were reduced in axons and dendrites, and accumulated in the somata without severe mitochondrial damage or neurodegeneration. In contrast, organization of microtubule or global axonal transport was not significantly altered at this stage. Abeta42-induced behavioral defects were exacerbated by genetic reductions in mitochondrial transport, and were modulated by cAMP levels and PKA activity. Levels of putative PKA substrate phosphoproteins were reduced in the Abeta42 fly brains. Importantly, perturbations in mitochondrial transport in neurons were sufficient to disrupt PKA signaling and induce late-onset behavioral deficits, suggesting a mechanism whereby mitochondrial mislocalization contributes to Abeta42-induced neuronal dysfunction. These results demonstrate that mislocalization of mitochondria underlies the pathogenic effects of Abeta42 in vivo.
Insights
Amyloid-beta 42 (Abeta42) causes Alzheimer's disease by mislocalizing mitochondria, disrupting neuronal function. This mitochondrial transport defect, not severe damage, underlies Abeta42's pathogenic effects in vivo.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alzheimer's disease (AD) pathogenesis involves amyloid-beta 42 (Abeta42).
- Mitochondrial dysfunction is observed in AD brains, but its role as an early event is unclear.
- Molecular mechanisms linking Abeta42 to neuronal dysfunction require elucidation.
Purpose of the Study:
- To investigate the role of mitochondrial mislocalization in Abeta42-induced neuronal dysfunction.
- To determine if mitochondrial transport defects are an early pathogenic event in Abeta42-mediated AD.
Main Methods:
- Utilized a transgenic Drosophila model expressing Abeta42.
- Assessed mitochondrial distribution in neurons (axons, dendrites, somata).
- Analyzed behavioral defects, cAMP levels, PKA activity, and phosphoprotein levels.
Main Results:
- Abeta42 expression led to mitochondrial accumulation in neuronal somata and reduction in axons/dendrites.
- Mitochondrial mislocalization, not severe damage, correlated with neuronal dysfunction.
- Impaired mitochondrial transport exacerbated Abeta42-induced behavioral deficits.
- Perturbing mitochondrial transport disrupted PKA signaling and caused late-onset behavioral deficits.
Conclusions:
- Mitochondrial mislocalization is a key pathogenic mechanism underlying Abeta42 toxicity in vivo.
- Disruption of mitochondrial transport contributes to Abeta42-induced neuronal dysfunction and behavioral deficits.
- Mitochondrial transport defects may represent an early event in Alzheimer's disease pathogenesis.
